Effect of a Mixture of Fibers and Carbohydrates on Intestinal Transit in Children Diagnosed With Functional Constipation
NCT ID: NCT04028258
Last Updated: 2020-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2018-02-13
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Group A: study product+wash out+control product
* Group B: control product+wash out+study product
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Inside Study: Oligosaccharides Versus Placebo in Functional Constipation
NCT04282551
Constipation Fiber Trial
NCT02193997
Randomised Controlled Trial of Efficacy of Resistant Maltodextrins on Reducing Colonic Transit Time
NCT01802112
Dose-ranging Efficacy of Polydextrose Supplement on Colonic Transit Time and Symptoms in Adults With Functional Constipation
NCT02314936
Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time
NCT01540669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Supplement under study: mixture of food fibers of plant origin, in a proportion that contributes 75% soluble fiber / 25% insoluble fiber.
* Control: Placebo supplement: maltodextrin and plum flakes
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: study+wash out+control
Study product (3 weeks) + wash out (2 weeks) + control product (3 weeks)
Mixture of fibers + Placebo
Study product: mixture of plant-based food fibers (3 weeks) + wash out (2 weeks) + placebo control : plum flakes + maltodextrin (3 weeks)
Group B: control+wash out+study
Control product (3 weeks) + wash out (2 weeks) + study product (3 weeks)
Placebo + Mixture of fibers
Placebo control: plum flakes + maltodextrin (3 weeks) + wash out (2 weeks) + study product: mixture of plant-based food fibers (3 weeks)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mixture of fibers + Placebo
Study product: mixture of plant-based food fibers (3 weeks) + wash out (2 weeks) + placebo control : plum flakes + maltodextrin (3 weeks)
Placebo + Mixture of fibers
Placebo control: plum flakes + maltodextrin (3 weeks) + wash out (2 weeks) + study product: mixture of plant-based food fibers (3 weeks)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of functional constipation according to Rome IV criteria
Exclusion Criteria
* Use of medications that cause constipation
* Children with organic constipation such as Hirschsprung's disease, cerebral paralysis, anorectal and spinal cord abnormalities and metabolic diseases.
* Patients who are not likely to complete follow-up
3 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratorios Ordesa
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerardo Rodríguez, MD
Role: PRINCIPAL_INVESTIGATOR
Instituto de Investigación Sanitaria Aragón
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro de Salud Perpetuo Socorro
Huesca, Aragon, Spain
Centro de Salud Amparo Poch
Zaragoza, Aragon, Spain
Centro de Salud Isabel II
Santander, Cantabria, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jorge Fuertes, MD
Role: primary
Isabel Lostal, MD
Role: primary
Maria Rosa Pardo
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VEGY-DOWN (A)-05-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.